Viz.ai has entered a collaboration with Alnylam to advance earlier identification and streamline diagnosis for cardiac amyloidosis.

MSD has signed a multi-year research collaboration with Quotient Therapeutics to discover new drug targets for IBD.

Gilead acquired Arcellx to gain the development and marketing rights to anito-cel, for which GlobalData forecasts sales of ...

Biopharma labs run with the aid of autonomous systems like robotic arms, guided by artificial intelligence (AI), could leave scientists free to focus on the broader direction of research. Photo by ...

Gilead may collaborate with Galapagos to develop Ouro's in-licensed gamgertamig for the treatment of B-cell mediated autoimmune diseases.

The healthcare landscape has undergone a rapid transformation worldwide over the past decade. COVID-19 played a massive role ...

Fast-track qualifications are becoming a popular option for people wanting to start “real life” faster. Compared to traditional degree programs, they allow you to finish your education faster. If ...

Monash University and ClinChoice have announced a strategic partnership to accelerate clinical development of new therapies.

Sanofi and Kali Therapeutics have signed an exclusive global licence agreement for KT501, a new tri-specific antibody for B cell-mediated autoimmune diseases.

Clinical trial data managers must prepare for the use of AI in processes. Credit: via Shutterstock. AI in clinical trials has the potential to offer faster insights, greater efficiency, and improved ...

Backed by partner Sanofi, Earendil will expand the utility of its AI-driven drug discovery platform, while progressing its ...

ImmunityBio has received approval from the Macau Special Administrative Region for Anktiva in combination with BCG for bladder cancer.